日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial

SHR-A1811，一种新型靶向 HER2 的抗体药物偶联物，在晚期实体瘤中的应用（HORIZON-X）：一项全球 1 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02612-9
Yao, Herui; Yan, Min; Tong, Zhongsheng; Wu, Xinhong; Yin, Yongmei; Ryu, Min-Hee; Park, John J; Jiang, Shusuan; Kim, Jee Hyun; Wang, Shouman; Zhong, Yahua; Voskoboynik, Mark; Zhang, Jian; Kaubisch, Andreas; Liu, Caigang; Chen, Yu; Im, Seock-Ah; Wu, Lingying; Liu, Yingbin; Ganju, Vinod; Barve, Minal; Li, Hui; Yao, Guangyu; Yang, Mudan; Bao, Lequn; Zhao, Yiming; Zhao, Jianli; Zhao, Kaijing; Shen, Yu; Rong, Shangyi; Zhu, Xiaoyu; Song, Erwei
HER2
发表日期：2026
文献求助 收藏

Non-contact optical spectroscopy for metabolic and vascular characterizations of orthotopic tongue cancer models in vivo

非接触式光学光谱技术用于体内原位舌癌模型代谢和血管特征分析

期刊:IEEE Journal of Selected Topics in Quantum Electronics
影响因子:5.1
doi:10.1109/jstqe.2025.3635031
Hasan, Md Zahid; Yan, Jing; Sarker, Sumit; Saha, Pranto Soumik; Zhu, Caigang
肿瘤
肿瘤免疫
代谢
发表日期：2026
文献求助 收藏

Combined autofluorescence and diffuse reflectance spectroscopy for rapid metabolic and vascular characterizations of orthotopic tongue tumors in vivo

结合自发荧光和漫反射光谱技术，可快速对原位舌肿瘤进行体内代谢和血管特征分析。

期刊:Biomedical Optics Express
影响因子:3.2
doi:10.1364/BOE.589203
Saha, Pranto Soumik; Yan, Jing; Sarker, Sumit; Hasan, Md Zahid; Zhu, Caigang
肿瘤
IF
肿瘤免疫
代谢
发表日期：2026
文献求助 收藏

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效：一项多中心、开放标签、单臂 1/2 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02155-5
Ruan, Dan-Yun; Huang, Wen-Wen; Li, Yongsheng; Zhao, Yanqiu; Shi, Yehui; Jia, Yuming; Cang, Shundong; Zhang, Wei; Shi, Jianhua; Chen, Jun; Lin, Jie; Liu, Yunpeng; Xu, Jianming; Ouyang, Weiwei; Fang, Jian; Zhuang, Wu; Liu, Caigang; Bu, Qing; Li, Manxiang; Meng, Xiangjiao; Sun, Meili; Yang, Nong; Dong, Xiaorong; Pan, Yueyin; Li, Xingya; Qu, Xiujuan; Zhang, Tongmei; Yuan, Xianglin; Hu, Sheng; Guo, Wei; Li, Yalun; Li, Shengqing; Liu, Dongying; Song, Feixue; Tan, Liping; Yu, Yan; Yu, Xinmin; Zang, Aimin; Sun, Chang; Zhang, Qian; Zou, Kai; Dan, Mo; Xu, Rui-Hua; Zhao, Hongyun
肺癌
肿瘤
肿瘤免疫
RET
细胞生物学
发表日期：2025
文献求助 收藏

CD8(+) TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients

新辅助免疫化疗后坏死肿瘤中的CD8(+)肿瘤浸润淋巴细胞可预测非小细胞肺癌患者的预后

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02435-0
Lin, Haifeng; Han, Yi; Guo, Lei; Liu, Caigang; Li, Hefei; Li, Jie; Wang, Chong; Zhou, Lijuan; Zhang, Xiangna; Sun, Lisha; Zhang, Ying Yi; Chu, Xiaojing; Shi, Jianquan; Cao, Xiaoqing; Chen, Yifang; Qin, Zhiqing; Bao, Jiaming; Wan, Shiya; Chen, Hao; Tang, Xiaoran; Li, Xiang; Wang, Xinyu; Cheng, Yuting; Li, Yixia; Zhang, Jie; Liu, Chang; Zhang, Xuguang; Wang, Yanan; Hu, Yi; Che, Nanying; Xu, Xiaowei; Lu, Hezhe
肺癌
肿瘤
T细胞
肿瘤免疫
CD8
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Correction: Targeting SOST using a small‑molecule compound retards breast cancer bone metastasis

更正：使用小分子化合物靶向SOST可延缓乳腺癌骨转移

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02322-w
Sun, Lisha; Zhang, Yixiao; Chen, Guanglei; Ji, Yaoting; Ma, Qingtian; Qiao, Xinbo; Wu, Sijin; Zhou, Lin; Bu, Jiawen; Zhu, Xudong; Zhang, Xiaoying; Jiang, Xiaofan; Liu, Chao; Li, Xinnan; Liu, Yang; Yang, Yongliang; Liu, Caigang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies

从机制到应用：纳米医学驱动的癌症治疗中的程序性细胞死亡通路

期刊:Bioactive Materials
影响因子:20.3
doi:10.1016/j.bioactmat.2025.06.052
Zhang, Zhan; Wu, Yuanzhen; Liu, Yanchen; Zhang, Jingyu; Zhang, Yan; Dai, Yunlu; Liu, Caigang
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial

新辅助 ARX788 联合吡咯替尼对比曲妥珠单抗、帕妥珠单抗、多西他赛和卡铂治疗 HER2 阳性乳腺癌：一项随机 2b 期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-61213-2
Niu, Nan; Xue, Jinqi; Chen, Guanglei; Qiu, Fang; Xu, Qianshi; Zheng, Xinyu; Liu, Chao; Zhao, Yafei; Gu, Xi; Zhao, Yi; Xu, Hong; Zhang, Hao; He, Guijin; Li, Ke; Li, Pengfei; Chen, Xiaoying; Li, Yong; Wang, Shuo; Zhu, Demiao; Liu, Tong; Xing, Fei; Xu, Yongqing; Han, Ye; Tang, Meiyue; Liu, Mingxin; Jiao, Gege; Jiang, Xiaofan; Yuen, Tony; Pang, Zheng; Liu, Caigang
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Emerging cGAS-STING Agonist-Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

基于cGAS-STING激动剂的新型纳米疗法：机制解析及其在癌症联合治疗中的应用

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202509890
Wang, Zhaomeng; Wang, Yongjun; He, Zhonggui; Liu, Caigang
STING
肿瘤
cGAS-STING
肿瘤免疫
发表日期：2025
文献求助 收藏

Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial

新辅助西达胺联合化疗治疗激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者（MUKDEN 05）：一项多中心、单臂、II期临床试验

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101700
Xue, Jinqi; Shan, Huilian; Qiu, Fang; Niu, Nan; Chen, Guanglei; Xu, Qianshi; Gu, Xi; Xing, Fei; Xu, Yongqing; Zheng, Xinyu; He, Guijin; Xu, Hong; Zhang, Hao; Song, Dong; Han, Ye; Tang, Meiyue; Cao, Shuo; Song, Yang; Zheng, Ran; Zhao, Yafei; Jiao, Gege; Liu, Mingxin; Liu, Caigang
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏